| Interim Report for the First Nine Months of 2017 |
Download |
| A Phase IIa Study of Tisotumab Vedotin (HuMax®-TF-ADC) in Patients With Relapsed, Recurrent and/or Metastatic Cervical Cancer: Updated Safety and Efficacy – ESGO E-poster – November 2017 (Concin) |
Download |
| Genmab First Nine Months of 2017 Results Presentation |
Download |
| Investor Presentation, September 2017 |
Download |
| Interim Report for the First Half 2017 |
Download |
| Genmab First Half 2017 Results Presentation |
Download |
| Interim Report for the First Quarter 2017 |
Download |
| 10th Kempen & Co. Life Science Conference - April 2017 |
Download |
| AGM 2017 Presentation |
Download |
| Genmab Q1 2017 Results Presentation |
Download |
| Election Results of the Annual General Meeting 2017 |
Download |
| 35th Annual J.P. Morgan Healthcare Conference, San Francisco, CA, US - January 2017 |
Download |
| Corporate Governance Report 2016 - English |
Download |
| Full Year 2016 Results Presentation |
Download |
| Genmab 2016 Annual Report |
Download |
| CSR Report 2016 - English |
Download |
| Genmab's ASH 2016 Data Review Meeting, San Diego, CA - December 2016 |
Download |
| Jefferies London Healthcare Conference, London, UK - November 2016 |
Download |
| Interim Report for the Nine Months Ended September 30, 2016 |
Download |
| Q3 2016 Results Presentation |
Download |
| Bank of America Merrill Lynch Global Healthcare Conference, London, UK - September 2016 |
Download |
| Interim Report First Half 2016 |
Download |
| First Half 2016 Results Presentation |
Download |
| Goldman Sachs 37th Annual Global Healthcare Conference, Rancho Palos Verdes, CA, US - June 2016 |
Download |
| Interim Report First Quarter 2016 |
Download |
| 9th Kempen & Co Life Sciences Conference, Amsterdam, NL - April 2016 |
Download |
